KPMG LLP Chartered Professional Accountants PO Box 10426 777 Dunsmuir Street Vancouver BC V7Y 1K3 Telephone (604) 691-3000 Fax (604) 691-3031 www.kpmg.ca REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Board of Directors Mogo Inc.: Opinion on the Consolidated Financial Statements We have audited the accompanying consolidated statements of financial position of Mogo Inc. (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations and comprehensive income (loss), changes in equity (deficit), and cash flows for each of the years in the three-year period ended December 31, 2022, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and its financial performance and its cash flows for each of the years in the three-year period ended December 31, 2022, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.Basis for Opinion These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. /s/ KPMG LLP Chartered Professional Accountants We have served as the Company’s auditor since 2019. Vancouver, Canada March 23, 2023 © 2022 KPMG LLP, an Ontario limited liability partnership and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved. |
Note |
December 31, 2022 |
December 31, 2021 |
||||||||||
Assets |
||||||||||||
Cash and cash equivalent |
||||||||||||
Restricted cash |
||||||||||||
Digital assets |
6 | |||||||||||
Loans receivable, net |
4 | |||||||||||
Prepaid expenses, and other receivables and assets |
5 | |||||||||||
Investment portfolio |
7,25 | |||||||||||
Investment accounted for using the equity method |
19 | |||||||||||
Property and equipment |
8 | |||||||||||
Right-of-use |
10 | |||||||||||
Intangible assets |
9 | |||||||||||
Derivative financial assets |
20 | |||||||||||
Goodwill |
24 | |||||||||||
|
|
|
|
|||||||||
Total assets |
||||||||||||
|
|
|
|
|||||||||
Liabilities |
||||||||||||
Accounts payable, accruals and other |
11 | |||||||||||
Lease liabilities |
10 | |||||||||||
Credit facility |
12 | |||||||||||
Debentures |
13 | |||||||||||
Derivative financial liabilities |
14 | |||||||||||
Deferred tax liability |
21 | |||||||||||
|
|
|
|
|||||||||
Total liabilities |
||||||||||||
|
|
|
|
|||||||||
Equity |
||||||||||||
Share capital |
27a | |||||||||||
Contributed surplus |
||||||||||||
Revaluation reserve |
6 | |||||||||||
Foreign currency translation reserve |
||||||||||||
Deficit |
( |
) |
( |
) | ||||||||
|
|
|
|
|||||||||
Total equity |
||||||||||||
|
|
|
|
|||||||||
Total equity and liabilities |
||||||||||||
|
|
|
|
Year ended |
||||||||||||||||
Note |
December 31, 2022 |
December 31, 2021 |
December 31, 2020 |
|||||||||||||
Revenue |
||||||||||||||||
Subscription and services |
||||||||||||||||
Interest revenue |
||||||||||||||||
15a | ||||||||||||||||
Cost of revenue |
||||||||||||||||
Provision for loan losses, net of recoveries |
4 | |||||||||||||||
Transaction costs |
||||||||||||||||
Gross profit |
||||||||||||||||
Operating expenses |
||||||||||||||||
Technology and development |
||||||||||||||||
Marketing |
||||||||||||||||
Customer service and operations |
||||||||||||||||
General and administration |
||||||||||||||||
Stock-based compensation |
27c | |||||||||||||||
Depreciation and amortization |
8,9,10 | |||||||||||||||
Total operating expenses |
16 | |||||||||||||||
Loss from operations |
( |
) |
( |
) | ||||||||||||
Other expenses (income) |
||||||||||||||||
Credit facility interest expense |
12 | |||||||||||||||
Debenture and other financing expense |
13,28 | |||||||||||||||
Accretion related to debentures and convertible debentures |
13 | |||||||||||||||
Share of loss in investment accounted for using the equity method |
19 | |||||||||||||||
Revaluation loss (gain) |
17 | ( |
) | |||||||||||||
Impairment of investment accounted for using the equity method |
19 | |||||||||||||||
Impairment of goodwill |
24 | |||||||||||||||
Other non-operating expense(income) |
18 | ( |
) | |||||||||||||
( |
) | |||||||||||||||
Net loss before tax |
( |
) |
( |
) | ( |
) | ||||||||||
Income tax recovery |
( |
) |
( |
) | ||||||||||||
Net loss |
( |
) |
( |
) | ( |
) | ||||||||||
Other comprehensive income: |
||||||||||||||||
Items that will not be reclassified subsequently to profit or loss: |
||||||||||||||||
Unrealized revaluation (loss) gain on digital assets |
6 | ( |
) |
|||||||||||||
Items that are or may be reclassified subsequently to profit or loss: |
||||||||||||||||
Foreign currency transaction reserve gain |
||||||||||||||||
Other comprehensive (loss) income |
( |
) |
||||||||||||||
Total comprehensive loss |
( |
) |
( |
) | ( |
) | ||||||||||
Net loss per share |
22 | |||||||||||||||
Basic loss per share |
( |
) |
( |
) | ( |
) | ||||||||||
Diluted loss per share |
( |
) |
( |
) | ( |
) | ||||||||||
Weighted average number of basic common shares (in 000s) |
||||||||||||||||
Weighted average number of fully diluted common shares (in 000s) |
||||||||||||||||
Number of shares, net of treasury shares (000s) |
Share capital |
Contributed surplus |
Revaluation reserve |
Foreign currency translation reserve |
Deficit |
Total |
||||||||||||||||||||||
Balance, December 31, 2021 |
( |
) |
||||||||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
( |
) |
( |
) | |||||||||||||||||||
Purchase of common shares for cancellation (Note 27a) |
( |
) |
( |
) |
— |
— |
— |
— |
( |
) | ||||||||||||||||||
Cancellation of replacement awards |
( |
) |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||
Foreign currency translation reserve |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Revaluation reserve (Note 6) |
— |
— |
— |
( |
) |
— |
— |
( |
) | |||||||||||||||||||
Stock-based compensation (Note 27c) |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Options and restricted share units (“RSUs”) exercised or converted |
( |
) |
— |
— |
— |
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance, December 31, 2022 |
( |
) |
||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares, net of treasury shares (000s) |
Share capital |
Contributed surplus |
Revaluation reserve |
Foreign currency translation reserve |
Deficit |
Total |
||||||||||||||||||||||
Balance, December 31, 2020 |
— |
— |
( |
) |
||||||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
( |
) |
( |
) | |||||||||||||||||||
Treasury shares reserve (Note 27b) |
( |
) |
( |
) |
— |
— |
— |
— |
( |
) | ||||||||||||||||||
Foreign currency translation reserve |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Revaluation reserve (Note 6) |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Stock-based compensation (Note 27c & Note 27e) |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Options and RSUs exercised or converted |
( |
) |
— |
— |
— |
|||||||||||||||||||||||
Shares issued – ATM arrangement, net |
— |
— |
— |
— |
||||||||||||||||||||||||
Shares issued – Registered direct offerings |
— |
— |
— |
|||||||||||||||||||||||||
Shares issued on acquisition of Carta |
— |
— |
— |
— |
||||||||||||||||||||||||
Shares issued on acquisition of Moka |
— |
— |
— |
— |
||||||||||||||||||||||||
Shares issued – Replacement awards |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||||
Shares issued on acquisition of Fortification |
— |
— |
— |
— |
||||||||||||||||||||||||
Shares issued on investment accounted for using the equity method |
— |
— |
— |
— |
||||||||||||||||||||||||
Shares issued – Convertible debentures |
— |
— |
— |
— |
||||||||||||||||||||||||
Equity settled share-based payment |
— |
— |
— |
— |
||||||||||||||||||||||||
Warrants issued for broker services (Note 27e) |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Warrants exercised (Note 27e) |
( |
) |
— |
— |
— |
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance, December 31, 2021 |
( |
) |
||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares, net of treasury shares (000s) |
Share capital |
Contributed surplus |
Revaluation reserve |
Foreign currency translation reserve |
Deficit |
Total |
||||||||||||||||||||||
Balance, December 31, 2019 |
— |
— |
( |
) |
||||||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
( |
) |
( |
) | |||||||||||||||||||
Stock-based compensation (Note 27c & Note 27e) |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Options and RSUs exercised or converted |
( |
) |
— |
— |
— |
|||||||||||||||||||||||
Shares issued – Debentures |
— |
— |
— |
— |
||||||||||||||||||||||||
Equity portion – Convertible debentures |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Shares issued – Convertible debentures |
— |
— |
— |
— |
||||||||||||||||||||||||
Shares issued – Partial settlement of credit facility |
— |
— |
— |
— |
||||||||||||||||||||||||
Shares issued to settle debt |
— |
— |
— |
— |
||||||||||||||||||||||||
Warrants issued (Note 27e) |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Conversion of warrants (Note 27e) |
( |
) |
— |
— |
— |
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance, December 31, 2020 |
( |
) |
||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended |
||||||||||||||||
Cash provided by (used in) the following activities: |
Note |
December 31, 2022 |
December 31, 2021 |
December 31, 2020 |
||||||||||||
Operating activities |
||||||||||||||||
Net loss |
( |
) |
( |
) | |
|
( |
) | ||||||||
Items not affecting cash and other items : |
|
|
|
| ||||||||||||
Depreciation and amortization |
8,9,10 | |
|
|
| |||||||||||
Provision for loan losses |
4 | |
|
|
| |||||||||||
Credit facility interest expense |
12 | |
|
|
| |||||||||||
Debenture and other financing expense |
13,28 | |
|
|
| |||||||||||
Accretion related to debentures and convertible debentures |
13 | |
|
|
| |||||||||||
Share of loss in investment accounted for using the equity method |
19 | |
|
|
| |||||||||||
Stock-based compensation expense |
27c | |
|
|
| |||||||||||
Revaluation loss (gain) |
17 | ( |
) | |
|
|
| |||||||||
Impairment of investment using the equity method |
19 | |
|
|
| |||||||||||
Impairment of goodwill |
24 | | ||||||||||||||
Other non-operating expense(income) |
|
|
( |
) | ||||||||||||
Income tax recovery |
( |
) |
( |
) | |
|
| |||||||||
|
|
|
|
|
|
|
| |||||||||
( |
) | |
|
| ||||||||||||
Changes in: |
|
|
| |||||||||||||
Net issuance of loans receivable |
( |
) |
( |
) | |
|
| |||||||||
Proceeds from sale of loan book |
||||||||||||||||
Prepaid expenses, and other receivables and assets |
5 | ( |
) |
( |
) | |
|
| ||||||||
Accounts payable, accruals and other |
11 | ( |
) |
|
( |
) | ||||||||||
Restricted cash |
( |
) |
( |
) | | |||||||||||
|
|
|
|
|
|
|
| |||||||||
Cash (used in) provided by operating activities |
( |
) |
( |
) | |
|
| |||||||||
Interest paid |
( |
) |
( |
) | |
( |
) | |||||||||
Income taxes paid |
( |
) |
|
|
| |||||||||||
|
|
|
|
|
|
|
| |||||||||
Net cash (used in) provided by operating activities |
( |
) |
( |
) |
|
|
| |||||||||
|
|
|
|
|
|
|
| |||||||||
|
|
| ||||||||||||||
Investing activities |
|
|
| |||||||||||||
Investment in intangible assets |
9 | ( |
) |
( |
) | |
|
( |
) | |||||||
Cash invested in investment portfolio |
7,25 | ( |
) |
( |
) | |
|
( |
) | |||||||
Proceeds from sale of (investment in) digital assets |
6 | ( |
) | |
|
|
| |||||||||
Proceeds from sale of investments |
|
|
|
| ||||||||||||
Purchases of property and equipment |
8 | ( |
) |
( |
) | |
|
( |
) | |||||||
Cash invested in investment using the equity method |
( |
) | |
|
|
| ||||||||||
Cash acquired upon acquisition of subsidiary |
|
|
| |||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net cash used in investing activities |
( |
) |
( |
) | |
( |
) | |||||||||
|
|
|
|
|
|
|
| |||||||||
|
|
| ||||||||||||||
Financing activities |
|
|
| |||||||||||||
Lease liabilities – principal payments |
10 | ( |
) |
( |
) | |
( |
) | ||||||||
Repayments on debentures |
13 | ( |
) |
( |
) | |
( |
) | ||||||||
Net advances ( repayments) on credit facility |
12 | |
( |
) | ||||||||||||
Proceeds from issuance of common shares, net |
|
|
| |||||||||||||
Repurchase of common shares |
27a | ( |
) |
|
|
| ||||||||||
Proceeds from exercise of warrants |
|
|
| |||||||||||||
Proceeds from exercise of options |
|
|
| |||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net cash (used in) provided by financing activities |
( |
) |
|
( |
) | |||||||||||
|
|
|
|
|
|
|
| |||||||||
|
|
| ||||||||||||||
Effect of exchange rate fluctuations on cash and cash equivalents |
|
|
| |||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net (decrease) increase in cash and cash equivalent |
( |
) |
|
|
| |||||||||||
|
|
|
|
|
|
|
| |||||||||
Cash and cash equivalent, beginning of period |
|
|
| |||||||||||||
|
|
|
|
|
|
|
| |||||||||
Cash and cash equivalent, end of period |
|
|
| |||||||||||||
|
|
|
|
|
|
|
|
1. |
Nature of operations |
2. |
Basis of presentation |
2. |
Basis of presentation (Continued from previous page) |
● |
The Company has power over the entity whereby the Company has the ability to direct the relevant activities (i.e., the activities that affect the entity’s returns); |
● |
The Company is exposed, or has rights, to variable returns from its involvement with the entity; and |
● |
The Company has the ability to use its power over the entity to affect the amount of the entity’s returns. |
3. |
Significant accounting policies |
a) |
Revenue recognition |
3. |
Significant accounting policies (Continued from previous page) |
a) |
Revenue recognition (Continued from previous page) |
b) |
Cost of revenue |
3. |
Significant accounting policies (Continued from previous page) |
c) |
Financial instruments |
● | it is held within a business model whose objective is to hold assets to collect contractual cash flows; and |
● | its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. |
● | it is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and |
● | its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. |
3. |
Significant accounting policies (Continued from previous page) |
c) |
Financial instruments (Continued from previous page) |
3. |
Significant accounting policies (Continued from previous page) |
c) |
Financial instruments (Continued from previous page) |
d) |
Property and equipment |
Rate | ||
Computer equipment |
||
Furniture and fixtures |
||
Leasehold improvements |
3. |
Significant accounting policies (Continued from previous page) |
e) |
Intangible assets |
Rate | ||
Software - Internally generated |
||
Software licenses |
||
Technology assets - Acquired |
||
Customer relationships |
||
Regulatory licenses |
||
Brand and trade name |
● | the technical feasibility of completing the intangible asset so that it will be available for use or sale; |
● | its intention to complete and its ability to use or sell the asset; |
● | how the asset will generate future economic benefits; |
● | the availability of resources to complete the asset; and |
● | the ability to measure reliably the expenditure during development. |
f) |
Goodwill |
3. |
Significant accounting policies (Continued from previous page) |
g) |
Impairment of non-financial assets |
● | Carta; and |
● | Remaining Mogo related entities. |
h) |
Digital assets |
3. |
Significant accounting policies (Continued from previous page) |
h) |
Digital assets (Continued from previous page) |
i) |
Foreign currency translation |
j) |
Foreign operations |
k) |
Provisions |
l) |
Income taxes |
3. |
Significant accounting policies (Continued from previous page) |
m) |
Sales tax |
n) |
Share-based payments |
o) |
Earnings per share |
3. |
Significant accounting policies (Continued from previous page) |
p) |
Business combinations |
q) |
Investment in associate |
3. |
Significant accounting policies (Continued from previous page) |
r) |
Cash and cash equivalent |
s) |
Leases |
t) |
Government assistance |
3. |
Significant accounting policies (Continued from previous page) |
u) |
Significant accounting judgements, estimates and assumptions |
(i) |
Allowance for loan losses |
3. |
Significant accounting policies (Continued from previous page) |
u) |
Significant accounting judgements, estimates and assumptions (Continued from previous page) |
(ii) |
Fair value of privately held investments |
(iii) |
Valuation of goodwill acquired in business combinations |
(iv) |
Impairment of investment in associate |
v) |
New and amended standards and interpretations |
4. |
Loans receivable |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Current (terms of one year or less) |
||||||||
Non-current (terms exceeding one year) |
||||||||
As at December 31, 2022 |
||||||||||||||||||
Risk Category |
Days past due |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
|||||||||||||
Strong |
— |
— |
||||||||||||||||
Lower risk |
1-30 days past due |
— |
— |
|||||||||||||||
Medium risk |
31-60 days past due |
— |
— |
|||||||||||||||
Higher risk |
61-90 days past due |
— |
— |
|||||||||||||||
Non-performing |
— |
— |
||||||||||||||||
Gross loans receivable |
||||||||||||||||||
Allowance for loan losses |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||
Loans receivable, net |
||||||||||||||||||
4. |
Loans receivable (Continued from previous page) |
As at December 31, 2021 |
||||||||||||||||||
Risk Category |
Days past due |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
|||||||||||||
Strong |
— |
— |
||||||||||||||||
Lower risk |
1-30 days past due |
— |
— |
|||||||||||||||
Medium risk |
31-60 days past due |
— |
— |
|||||||||||||||
Higher risk |
61-90 days past due |
— |
— |
|||||||||||||||
Non-performing |
— |
— |
||||||||||||||||
Gross loans receivable |
||||||||||||||||||
Allowance for loan losses |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||
Loans receivable, net |
||||||||||||||||||
As at December 31, 2022 |
||||||||||||||||
Stage 1 |
Stage 2 |
Stage 3 |
Total |
|||||||||||||
Balance as at January 1, 2022 |
||||||||||||||||
Gross loans originated |
— |
— |
||||||||||||||
Principal payments |
( |
) |
( |
) |
( |
) | ( |
) | ||||||||
Re-measurement of allowance before transfers |
||||||||||||||||
Re-measurement of amounts transferred between stages |
( |
) |
||||||||||||||
Transfer to (from) |
||||||||||||||||
Stage 1 – 12 - month ECLs |
( |
) |
( |
) |
— |
|||||||||||
Stage 2 – Lifetime ECLs |
( |
) |
( |
) | — |
|||||||||||
Stage 3 – Lifetime ECLs |
( |
) |
( |
) |
— |
|||||||||||
Net amounts written off against allowance |
— |
— |
( |
) |
( |
) | ||||||||||
Balance as at December 31, 2022 |
||||||||||||||||
4. |
Loans receivable (Continued from previous page) |
As at December 31, 2021 |
||||||||||||||||
Stage 1 |
Stage 2 |
Stage 3 |
Total |
|||||||||||||
Balance as at January 1, 2021 |
||||||||||||||||
Gross loans originated |
— |
— |
||||||||||||||
Principal payments |
( |
) |
( |
) |
( |
) | ||||||||||
Re-measurement of allowance before transfers |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
Re-measurement of amounts transferred between stages |
( |
) |
||||||||||||||
Transfer to (from) |
||||||||||||||||
Stage 1 – 12-month ECLs |
( |
) |
( |
) |
— |
|||||||||||
Stage 2 – Lifetime ECLs |
( |
) |
— |
— |
||||||||||||
Stage 3 – Lifetime ECLs |
( |
) |
( |
) |
— |
|||||||||||
Net amounts written off against allowance |
— |
— |
( |
) |
( |
) | ||||||||||
Balance as at December 31, 2021 |
||||||||||||||||
Year ended |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Balance, beginning of the period |
||||||||
Provision for loan losses |
||||||||
Charge offs |
( |
) |
( |
) | ||||
Balance, end of the period |
||||||||
5. |
Prepaid expenses, and other receivables and assets |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Prepaid expenses |
||||||||
Accounts receivable |
||||||||
Brokerage firm receivables |
||||||||
Deposits and other receivables and assets |
||||||||
Total |
||||||||
6. |
Digital assets |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Balance, beginning of the period |
||||||||
Additions |
||||||||
Revaluation (loss) gain on digital assets through other comprehensive income |
( |
) |
||||||
Revaluation loss on digital assets through net income (loss) |
( |
) |
||||||
Disposals |
( |
) |
||||||
Balance, end of the period |
||||||||
7. |
Investment portfolio |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Equities |
||||||||
Other |
||||||||
Total |
||||||||
8. |
Property and equipment |
Computer equipment |
Furniture and fixtures |
Leasehold improvements |
Total |
|||||||||||||
Cost |
||||||||||||||||
Balance, December 31, 2020 |
||||||||||||||||
Additions |
— |
|||||||||||||||
Additions through business combinations |
— |
|||||||||||||||
Effects of movement in exchange rate |
( |
) |
( |
) |
— |
( |
) | |||||||||
Balance, December 31, 2021 |
||||||||||||||||
Additions |
— |
— |
||||||||||||||
Impairment |
( |
) |
— |
— |
( |
) | ||||||||||
Effects of movement in exchange rate |
( |
) |
— |
|||||||||||||
Balance, December 31, 2022 |
||||||||||||||||
Accumulated depreciation |
||||||||||||||||
Balance, December 31, 2020 |
||||||||||||||||
Depreciation |
— |
|||||||||||||||
Balance, December 31, 2021 |
||||||||||||||||
Depreciation |
— |
|||||||||||||||
Impairment |
( |
) |
— |
— |
( |
) | ||||||||||
Balance, December 31, 2022 |
||||||||||||||||
Net book value |
||||||||||||||||
Balance, December 31, 2021 |
— |
|||||||||||||||
Balance, December 31, 2022 |
— |
|||||||||||||||
9. |
Intangible assets |
Internally generated– completed |
Internally generated– in progress |
Software licenses |
Acquired technology assets |
Customer relationships |
Brand |
Regulatory licenses |
Total |
|||||||||||||||||||||||||
Cost |
||||||||||||||||||||||||||||||||
Balance, December 31, 2020 | — | — | — | — | ||||||||||||||||||||||||||||
Additions | — | — | — | — | — | |||||||||||||||||||||||||||
Additions through a business combination | — | — | ||||||||||||||||||||||||||||||
Impairment | — | ( |
) | — | — | — | — | — | ( |
) | ||||||||||||||||||||||
Transfers | ( |
) | — | — | — | — | — | — | ||||||||||||||||||||||||
Effects of movement in exchange rate | — | — | ( |
) | — | — | — | — | ( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance, December 31, 2021 | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Additions | — | — | — | — | — | |||||||||||||||||||||||||||
Impairment | ( |
) | — | — | — | — | — | — | ( |
) | ||||||||||||||||||||||
Transfers | ( |
) | — | — | — | — | — | — | ||||||||||||||||||||||||
Effects of movement in exchange rate | — | — | ( |
) | — | — | — | — | ( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance, December 31, 2022 |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Accumulated amortization |
||||||||||||||||||||||||||||||||
Balance, December 31, 2020 | — | — | — | — | — | |||||||||||||||||||||||||||
Amortization | — | — | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance, December 31, 2021 | — | — | ||||||||||||||||||||||||||||||
Amortization | — | — | ||||||||||||||||||||||||||||||
Impairment | ( |
) | — | — | — | — | — | — | ( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance, December 31, 2022 |
— |
— |
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Net book value |
||||||||||||||||||||||||||||||||
Balance, December 31, 2021 | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance, December 31, 2022 |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10. |
Leases |
Right-of-use assets |
Lease liabilities |
|||||||
Balance, as at December 31, 2020 |
||||||||
Additions |
||||||||
Disposals |
( |
) |
( |
) | ||||
Depreciation |
( |
) |
— |
|||||
Interest expense |
— |
|||||||
Payments |
— |
( |
) | |||||
|
|
|
|
|||||
Balance, as at December 31, 2021 |
||||||||
Impairment |
( |
) |
— |
|||||
Depreciation |
( |
) |
— |
|||||
Interest expense |
— |
|||||||
Payments |
— |
( |
) | |||||
|
|
|
|
|||||
Balance, as at December 31, 2022 |
||||||||
|
|
|
|
Year ended |
|
|||||||||||
December 31, 2022 |
December 31, 2021 |
December 31, 2020 |
|
|||||||||
Depreciation of right-of-use assets |
|
|
| |||||||||
Interest expense on lease liabilities |
|
|
| |||||||||
Expenses relating to short term leases |
|
|
| |||||||||
Impairment |
— |
|
— |
| ||||||||
Variable lease payments |
|
|
| |||||||||
|
|
|
|
|
|
| ||||||
Total |
|
|
| |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
11. |
Accounts payable and accruals |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Accounts payables |
||||||||
Accrued expenses |
||||||||
Accrued wages and other benefits |
||||||||
Client liabilities |
||||||||
Other |
||||||||
Total |
||||||||
12. |
Credit facility |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Credit facility - funds drawn |
||||||||
13. |
Debentures |
i) | a reduction in the weighted average coupon interest rate, from approximately |
ii) | replacement of the former monthly interest payable by a new quarterly payment (the “Quarterly Payment”), the amount of which is fixed at |
iii) | settlement of the new Quarterly Payment on the first business day following the end of a calendar quarter at the Company’s option either in cash or Common Shares; and |
iv) | an option for all debenture holders to receive a lump-sum payout of their previously unpaid interest for the period from |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Principal balance |
||||||||
Discount |
( |
) |
( |
) | ||||
Interest payable |
||||||||
Principal component of quarterly payment |
Principal due on maturity |
Total |
||||||||||
2023 |
— |
|||||||||||
202 4 |
— |
|||||||||||
202 5 |
||||||||||||
14. |
Derivative financial liabilities |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Balance, beginning of the period |
||||||||
Stock warrants issued |
||||||||
Change in fair value due to revaluation of derivative financial liabilities |
( |
) |
( |
) | ||||
Change in fair value due to foreign exchange |
( |
) | ||||||
Balance, end of the period |
||||||||
Warrants outstanding and exercisable (000s) |
Weighted average exercise price $ |
|||||||
Balance, December 31, 2020 |
||||||||
Warrants issued |
||||||||
Balance, December 31, 2021 |
||||||||
Warrants issued |
||||||||
Balance, December 31, 2022 |
||||||||
14. |
Derivative financial liabilities (Continued from previous page) |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Risk-free interest rate |
||||||||
Expected life |
||||||||
Expected volatility in market price of shares |
||||||||
Expected dividend yield |
||||||||
Expected forfeiture rate |
||||||||
15. |
Geographic information |
(a) | Revenue |
Year ended |
||||||||||||
December 31, 2022 |
December 31, 2021 |
December 31, 2020 |
||||||||||
Canada |
||||||||||||
Europe |
||||||||||||
Other |
||||||||||||
Total |
||||||||||||
(b) | Non-current assets |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Canada |
||||||||
Europe |
||||||||
Other |
||||||||
Total |
||||||||
16. |
Expense by nature and function |
Year ended |
||||||||||||
December 31, 2022 |
December 31, 2021 |
December 31, 2020 |
||||||||||
Personnel expense |
|
|
||||||||||
Depreciation and amortization |
|
|
||||||||||
Marketing |
|
|
||||||||||
Stock-based compensation |
|
|
||||||||||
Hosting and software licenses |
|
|
||||||||||
Insurance and licenses |
|
|
||||||||||
Professional services |
|
|
||||||||||
Credit verification costs |
|
|
||||||||||
Premises |
|
|
||||||||||
Others |
|
|
||||||||||
|
|
|
|
|
|
|
||||||
Total |
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended |
|||||||||||||
December 31, 2022 |
December 31, 2021 |
December 31, 2020 |
|||||||||||
Technology and development |
|
|
| ||||||||||
Marketing |
|
|
|
| |||||||||
Customer service and operations |
|
|
|
| |||||||||
General and administration |
|
|
| ||||||||||
|
|
|
|
|
|
|
|
|
|
|
| ||
Total |
|
|
|
| |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
17. |
Revaluation loss (gain) |
|
|
|
|
|
Year ended |
|
|
|
| ||||
December 31, 2022 |
December 31, 2021 |
December 31, 2020 |
|||||||||||
Change in fair value due to revaluation of derivative financial asset |
|
( |
) |
|
|
|
| ||||||
Change in fair value due to revaluation of derivative financial liabilities |
|
( |
) |
( |
) |
|
|
|
| ||||
Realized gain on investment portfolio |
|
— |
( |
) |
|
|
— |
| |||||
Unrealized loss on investment portfolio |
|
|
|
|
| ||||||||
Loss on digital assets |
|
— |
|
|
— |
| |||||||
Unrealized exchange (gain) loss |
|
|
|
( |
) |
|
|
|
|
|
|
|
|
Unrealized gain on other receivable |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Loss related to property and equipment |
|
— |
— |
|
|
|
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |
Total |
|
( |
) |
|
|
|
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
18. |
Other non-operating expense (income) |
Year ended |
||||||||||||
December 31, 2022 |
December 31, 2021 |
December 31, 2020 |
||||||||||
Government grants |
|
( |
) |
( |
) |
|
|
( |
) | |||
Direct offering transaction costs allocated to derivative financial liabilities |
|
— |
|
|
— |
| ||||||
Restructuring charges |
|
|
|
— |
| |||||||
Impairment of intangible assets |
|
— |
|
|
— |
| ||||||
Acquisition costs and other |
|
|
|
|
| |||||||
Gain on sale of loan book |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Credit facility prepayment and related expenses |
|
|
— |
|
|
|
— |
|
|
|
|
|
Convertible debenture early conversion |
|
|
— |
|
|
|
— |
|
|
|
|
|
Gain on amendment of debentures |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Total |
|
|
|
( |
) | |||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
19. |
Investment accounted for using the equity method |
● | a right for Mogo to purchase |
● | a right for these certain selling shareholders to require Mogo to purchase |
● | the issuance of a warrant to Mogo to acquire |
● | the exercise of the Call Option, to acquire |
● | the purchase of |
19. |
Investment accounted for using the equity method (Continued from previous page) |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Balance, beginning of the period |
||||||||
Additions |
||||||||
Initial investments in Coinsquare |
||||||||
Step up investments in Coinsquare |
||||||||
Share of loss in investment accounted for using the equity method: |
||||||||
Share of investee’s loss |
( |
) |
( |
) | ||||
Gain from dilution of interest in associate |
||||||||
Impairment |
( |
) |
||||||
Balance, end of the period |
||||||||
19. |
Investment accounted for using the equity method (Continued from previous page) |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Current assets |
||||||||
Non-current assets |
||||||||
Current liabilities |
( |
) |
( |
) | ||||
Non-current liabilities |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Net assets |
||||||||
|
|
|
|
|||||
Company’s share of net assets |
||||||||
Intangible assets |
||||||||
Deferred tax liabilities |
( |
) |
( |
) | ||||
Goodwill |
||||||||
Impairment |
( |
) |
— |
|||||
|
|
|
|
|||||
Carrying amount of interest in associate |
||||||||
|
|
|
|
Year ended December 31, 2022 |
April 16, 2021 to December 31, 2021 |
|||||||
Revenue |
||||||||
Net income from continuing operations (100%) |
( |
) |
||||||
Post-tax loss from discontinued operations (100%) |
(412 |
) |
( |
) | ||||
Other comprehensive loss (100%) |
— |
( |
) | |||||
|
|
|
|
|||||
Total comprehensive income (100%) |
( |
) |
||||||
Company’s share of total comprehensive loss |
( |
) |
( |
) | ||||
Opening balance |
— |
|||||||
Initial investment in Coinsquare |
— |
|||||||
Step up investments in Coinsquare |
— |
|||||||
|
|
|
|
|||||
Total investments in Coinsquare |
||||||||
Share of loss in investment accounted for using the equity method: |
||||||||
Share of investee’s loss |
( |
) |
( |
) | ||||
Gain from dilution of interest in associate |
— |
|||||||
Impairment of investment |
( |
) |
— |
|||||
|
|
|
|
|||||
Carrying amount of equity accounted investment |
||||||||
|
|
|
|
|||||
Mogo’s share of: |
||||||||
Net income from continuing operations |
( |
) |
||||||
Post-tax loss from discontinued operations |
(140 |
) |
( |
) | ||||
Other comprehensive income |
— |
( |
) | |||||
Amortization of intangible assets |
( |
) |
( |
) | ||||
Amortization of deferred tax liabilities |
||||||||
|
|
|
|
|||||
Total other comprehensive loss |
( |
) |
( |
) | ||||
|
|
|
|
20. |
Derivative financial assets |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Balance, beginning of the period |
||||||||
Additions |
||||||||
Change in fair value due to revaluation of derivative financial assets |
( |
) |
||||||
Exercised |
( |
|||||||
|
|
|
|
|||||
Balance, end of the period |
||||||||
|
|
|
|
As at |
||||
December 31, 2021 |
||||
Risk-free interest rate |
||||
Expected life |
||||
Expected volatility in market price of shares |
||||
Expected dividend yield |
||||
Expected forfeiture rate |
||||
|
|
21. |
Income taxes |
a) | Provision for income taxes |
Year ended |
||||||||||||
December 31, 2022 |
December 31, 2021 |
December 31, 2020 |
||||||||||
Current tax expense |
||||||||||||
Deferred tax recovery |
( |
) | ( |
) |
||||||||
Income tax recovery |
( |
) | ( |
) |
||||||||
Year ended |
||||||||||||
December 31, 2022 |
December 31, 2021 |
December 31, 2020 |
||||||||||
Canadian federal and provincial recovery of income taxes using statutory rate of 0 – |
( |
) | ( |
) |
( |
) | ||||||
Change in unrecognized deductible temporary differences and unused tax losses |
||||||||||||
Permanent differences and other |
||||||||||||
Income tax recovery |
( |
) | ( |
) |
||||||||
b) |
Deferred tax assets |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Non-capital losses |
||||||||
Property and equipment |
— |
|||||||
Intangible assets |
— |
|||||||
Total |
||||||||
21. |
Income taxes (Continued from previous page) |
c) | Deferred tax liabilities |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Intangible assets |
||||||||
Right-of-use assets |
— |
|||||||
Property and equipment |
— |
|||||||
Digital assets and derivatives |
— |
|||||||
Equity investments |
— |
|||||||
Deferred cost |
— |
|||||||
d) | Deductible temporary differences and unused tax losses |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Unused tax losses |
||||||||
Property and equipment |
||||||||
Lease liability |
||||||||
Equity investments |
||||||||
Intangible assets |
||||||||
Investment accounted for using the equity method |
||||||||
Debentures |
||||||||
Financing costs |
||||||||
Research and development expenditures |
||||||||
Investment in subsidiaries |
||||||||
Other |
||||||||
21. |
Income taxes (Continued from previous page) |
d) | Deductible temporary differences and unused tax losses (Continued from previous page) |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Expires 2024 |
||||||||
Expires 2025 |
||||||||
Expires 2026 |
||||||||
Expires 2027 |
||||||||
Expires 2028 |
||||||||
Expires 2029 |
||||||||
Expires 2030 |
||||||||
Expires 2031 |
||||||||
Expires 2032 |
||||||||
Expires 2033 |
||||||||
Expires 2034 |
||||||||
Expires 2035 |
||||||||
Expires 2036 |
||||||||
Expires 2037 |
||||||||
Expires 2038 |
||||||||
Expires 2039 |
||||||||
Expires 2040 |
||||||||
Expires 2041 |
||||||||
Expires 2042 |
||||||||
22. |
Loss per share |
Year ended |
||||||||||||
December 31, 2022 |
December 31, 2021 |
December 31, 2020 |
||||||||||
Net loss attributed to shareholders |
( |
) |
( |
) |
( |
) | ||||||
Basic weighted average number of shares (in 000s) |
||||||||||||
Basic and diluted loss per share |
( |
) |
( |
) |
( |
) | ||||||
23. |
Capital management |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Share capital |
||||||||
Contributed surplus |
||||||||
Deficit |
( |
) |
( |
) | ||||
Credit facility |
||||||||
Debentures |
||||||||
24. |
Business combination |
January 25, 2021 |
||||
Assets acquired: |
||||
Cash and cash equivalent |
||||
Prepaids, and other receivables and assets |
||||
Property and equipment |
||||
Right-of-use assets |
||||
Intangible assets - technology assets |
||||
Intangible assets - customer relationships |
||||
Intangible assets - software licenses |
||||
Intangible assets - brand |
||||
Goodwill |
||||
Liabilities assumed: |
||||
Accounts payable, accruals & other |
||||
Lease liabilities |
||||
Net assets acquired at fair value |
||||
Share consideration |
||||
24. |
Business combination (Continued from previous page) |
May 4, 2021 |
||||
Assets acquired: |
||||
Cash and cash equivalent |
||||
Prepaids, and other receivables and assets |
||||
Property and equipment |
||||
Intangible assets - technology assets |
||||
Intangible assets - customer relationships |
||||
Intangible assets - regulatory licenses |
||||
Goodwill |
||||
Liabilities assumed: |
||||
Accounts payable, accruals & other |
||||
Deferred tax liabilities |
||||
Net assets acquired at fair value |
||||
Share consideration |
||||
Cash consideration |
||||
Total consideration transferred |
||||
24. |
Business combination (Continued from previous page) |
September 1, 2021 |
||||
Assets acquired: |
||||
Cash and cash equivalent |
||||
Prepaids, and other receivables and assets |
||||
Intangible assets - regulatory licenses |
||||
Goodwill |
||||
Liabilities assumed: |
||||
Accounts payable, accruals & other |
||||
Deferred tax liabilities |
||||
Net assets acquired at fair value |
||||
Share consideration |
||||
Cash consideration |
||||
Total consideration transferred |
||||
24. |
Business combination (Continued from previous page) |
● | Cash flows: Estimated cash flows were projected based on actual operating results from internal sources, estimated loan origination and volume growth, as well as industry and market trends. Estimated cash flows are primarily driven by forecasted revenues and operating costs, and are extended to a total of years with a terminal value calculation thereafter. |
● | Terminal value growth rate: The terminal growth rate was based on management’s estimate of long-term compound annual growth rates, historical and projected economic indicators, and projected industry growth. |
● | Pre-tax discount rate: The pre-tax discount rate is reflective of the CGUs Weighted Average Cost of Capital (“WACC”). The WACC was estimated based on the risk-free rate, equity risk premium, beta adjustment to the equity risk premium based on a direct comparison approach, an unsystematic risk premium, and an after-tax cost of debt based on the interest rate of the Company’s debts. |
● | Tax rate: The tax rates used in determining the future cash flows were those substantively enacted at the respective valuation date. |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Terminal growth rate |
||||||||
Pre-tax discount rate |
||||||||
24. |
Business combination (Continued from previous page) |
25. |
Fair value of financial instruments |
● | Level 1: Unadjusted quoted prices in an active market for identical assets and liabilities. |
● | Level 2: Quoted prices in markets that are not active or inputs that are derived from quoted prices of similar (but not identical) assets or liabilities in active markets. |
● | Level 3: Unobservable inputs that are supported by little or no market activity and are significant to the estimated fair value of the assets or liabilities. |
(a) | Valuation process |
25. |
Fair value of financial instruments (Continued from previous page) |
(b) |
Accounting classifications and fair values |
Carrying amount |
Fair value |
|||||||||||||||||||||||||||||||||||
As at December 31, 2022 |
Note |
FVTPL |
Financial asset at amortized cost |
Other financial liabilities |
Total |
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||||||||||||||||
Financial assets measured at fair value |
||||||||||||||||||||||||||||||||||||
Investment portfolio |
— | — | — | |||||||||||||||||||||||||||||||||
— | — | |||||||||||||||||||||||||||||||||||
Financial assets not measured at fair value |
||||||||||||||||||||||||||||||||||||
Cash and cash equivalent |
— | — | — | — | ||||||||||||||||||||||||||||||||
Restricted cash |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||
Loans receivable – current |
4 | — | — | — | — | |||||||||||||||||||||||||||||||
Loans receivable – non-current |
4 | — | — | — | — | |||||||||||||||||||||||||||||||
Other receivables |
— | — | — | — | ||||||||||||||||||||||||||||||||
— | — | |||||||||||||||||||||||||||||||||||
Financial liabilities measured at fair value |
||||||||||||||||||||||||||||||||||||
Derivative financial liabilities |
14 | — | — | — | — | |||||||||||||||||||||||||||||||
— | — | |||||||||||||||||||||||||||||||||||
Financial liabilities not measured at fair value |
||||||||||||||||||||||||||||||||||||
Accounts payable, accruals and other |
— | — | — | — | ||||||||||||||||||||||||||||||||
Credit facility |
12 | — | — | — | — | |||||||||||||||||||||||||||||||
Debentures |
13 | — | — | — | — | |||||||||||||||||||||||||||||||
— |
— |
|||||||||||||||||||||||||||||||||||
Carrying amount |
Fair value |
|||||||||||||||||||||||||||||||||||
As at December 31, 2021 |
Note |
FVTPL |
Financial asset at amortized cost |
Other financial liabilities |
Total |
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||||||||||||||||
Financial assets measured at fair value |
||||||||||||||||||||||||||||||||||||
Investment portfolio |
— | — | — | |||||||||||||||||||||||||||||||||
Derivative financial assets |
20 | — | — | — | — | |||||||||||||||||||||||||||||||
— | — | |||||||||||||||||||||||||||||||||||
Financial assets not measured at fair value |
||||||||||||||||||||||||||||||||||||
Cash and cash equivalent |
— | — | — | — | ||||||||||||||||||||||||||||||||
Restricted cash |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||
Loans receivable – current |
4 | — | — | — | — | |||||||||||||||||||||||||||||||
Loans receivable – non-current |
4 | — | — | — | — | |||||||||||||||||||||||||||||||
Other receivables |
— | — | — | — | ||||||||||||||||||||||||||||||||
— |
— |
|||||||||||||||||||||||||||||||||||
Financial liabilities measured at fair value |
||||||||||||||||||||||||||||||||||||
Derivative financial liabilities |
14 | — | — | — | — | |||||||||||||||||||||||||||||||
— |
— |
|||||||||||||||||||||||||||||||||||
Financial liabilities not measured at fair value |
||||||||||||||||||||||||||||||||||||
Accounts payable, accruals and other |
— | — | — | — | ||||||||||||||||||||||||||||||||
Credit facility |
12 | — | — | — | — | |||||||||||||||||||||||||||||||
Debentures |
13 | — | — | — | — | |||||||||||||||||||||||||||||||
— |
— |
|||||||||||||||||||||||||||||||||||
25. |
Fair value of financial instruments (Continued from previous page) |
(c) | Measurement of fair values: |
(i) | Valuation techniques and significant unobservable inputs |
Type |
Valuation technique |
Significant unobservable inputs |
Inter-relationship between significant unobservable inputs and fair value | |||
Investment portfolio: Equities Unlisted |
● Price of recent investments in the investee company ● Implied multiples from recent transactions of the underlying investee companies ● Offers received by investee companies ● Revenue multiples derived from comparable public companies and transactions ● Option pricing model |
● Third-party transactions ● Revenue multiples ● Balance sheets and last twelve-month revenues for certain of the investee companies ● Equity volatility ● Time to exit events |
● Increases in revenue multiples increases fair value ● Increases in equity volatility can increase or decrease fair value depending on class of shares held in the investee company ● Increases in estimated time to exit event can increase or decrease fair value depending on class of shares held in the investee company | |||
Partnership interest and others |
● Adjusted net book value |
● Net asset value per unit ● Change in market pricing of comparable companies of the underlying investments made by the partnership |
● Increases in net asset value per unit or change in market pricing of comparable companies of the underlying investment made by the partnership can increase fair value | |||
Loans receivable non-current |
● Discounted cash flows: Considering expected prepayments and using management’s best estimate of average market interest rates with similar remaining terms. |
● Expected timing and amount of cash flows ● Discount rate |
● Changes to the expected amount and timing of cash flow changes fair value ● Increases to the discount rate can decrease fair value | |||
Derivative financial assets |
● Option pricing model |
● Equity stock price and volatility |
● Increase in equity stock price and volatility will increase fair value |
25. |
Fair value of financial instruments (Continued from previous page) |
(i) | Valuation techniques and significant unobservable inputs (Continued from previous page) |
As at |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Balance, beginning of the period |
||||||||
Additions |
||||||||
Disposal |
— |
( |
) | |||||
Transfer to Level 1 investments |
( |
) |
— |
|||||
Unrealized exchange gain (loss) |
( |
) | ||||||
Realized gain on investment portfolio |
— |
|||||||
Unrealized loss on investment portfolio |
( |
) |
( |
) | ||||
Balance, end of the period |
||||||||
(ii) |
Sensitivity analysis |
Profit or loss |
||||||||
Increase |
Decrease |
|||||||
Investment portfolio: |
||||||||
December 31, 2022 Adjusted market multiple (5% movement) |
( |
) | ||||||
December 31, 2021 Adjusted market multiple (5% movement) |
( |
) |
26. |
Nature and extent of risk arising from financial instruments |
26. |
Nature and extent of risk arising from financial instruments (Continued from previous page) |
2023 |
2024 |
2025 |
2026 |
2027 |
Thereafter |
|||||||||||||||||||
Commitments - operational |
||||||||||||||||||||||||
Lease payments |
||||||||||||||||||||||||
Accounts payable |
— |
— |
— |
— |
— |
|||||||||||||||||||
Accruals and other |
— |
— |
— |
— |
— |
|||||||||||||||||||
Interest – Credit facility (Note 12) |
— |
— |
— |
|||||||||||||||||||||
Interest – Debentures (Note 13) |
— |
— |
— |
|||||||||||||||||||||
Commitments – principal repayments |
||||||||||||||||||||||||
Credit facility (Note 12) |
— |
— |
— |
— |
— |
|||||||||||||||||||
Debentures (Note 13) (1) |
— |
— |
— |
|||||||||||||||||||||
— |
— |
|||||||||||||||||||||||
Total contractual obligations |
||||||||||||||||||||||||
26. |
Nature and extent of risk arising from financial instruments (Continued from previous page) |
As at |
||||||||
($000 USD) |
December 31, 2022 |
December 31, 2021 |
||||||
Cash |
||||||||
Investment portfolio |
||||||||
Derivative financial liabilities |
( |
) |
( |
) | ||||
Debentures |
( |
) |
( |
) | ||||
26. |
Nature and extent of risk arising from financial instruments (Continued from previous page) |
27. |
Equity |
(a) | Share capital |
(b) | Treasury share reserve |
27. |
Equity (Continued from previous page) |
(c) | Options |
Options outstanding (000s) |
Weighted average grant date fair value $ |
Weighted average exercise price $ |
Options exercisable (000s) |
Weighted average exercise price $ |
||||||||||||||||
Balance, December 31, 2020 |
— |
|||||||||||||||||||
Options issued |
— |
— |
||||||||||||||||||
Exercised |
( |
) |
— |
— |
||||||||||||||||
Forfeited |
( |
) |
— |
— |
||||||||||||||||
Balance, December 31, 2021 |
— |
|||||||||||||||||||
Options issued |
— |
— |
||||||||||||||||||
Exercised |
( |
) |
— |
— |
||||||||||||||||
Forfeited |
( |
) |
— |
— |
||||||||||||||||
Balance, December 31, 2022 |
— |
|||||||||||||||||||
27. |
Equity (Continued from previous page) |
(c) |
Options (Continued from previous page) |
Year ended |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Risk-free interest rate |
||||||||
Expected life |
||||||||
Expected volatility in market price of shares |
||||||||
Expected dividend yield |
||||||||
Expected forfeiture rate |
||||||||
(d) | RSUs |
27. |
Equity (Continued from previous page) |
Number of RSUs (000s) |
||||
Balance, December 31, 2020 |
||||
Converted |
( |
) | ||
Expired |
( |
) | ||
Balance, December 31, 2021 |
||||
Converted |
( |
) | ||
Expired |
||||
Balance, December 31, 2022 |
||||
(e) |
Warrants |
Warrants outstanding (000s) |
Weighted average exercise price $ |
Warrants exercisable (000s) |
Weighted average exercise price $ |
|||||||||||||
Balance, December 31, 2020 |
||||||||||||||||
Warrants issued |
— |
— |
||||||||||||||
Warrants exercised |
( |
) |
— |
— |
||||||||||||
Balance, December 31, 2021 |
||||||||||||||||
Warrants issued |
— |
— |
— |
— |
||||||||||||
Warrants exercised |
— |
— |
||||||||||||||
Warrants expired |
— |
— |
— |
— |
||||||||||||
Balance, December 31, 2022 |
||||||||||||||||
27. |
Equity (Continued from previous page) |
(e) |
Warrants (Continued from previous page) |
Year ended | ||
December 31, 2021 | ||
Risk-free interest rate |
||
Expected life |
||
Expected volatility in market price of shares |
||
Expected dividend yield |
||
Expected forfeiture rate |
||
28. |
Related party transactions |
Year ended |
||||||||
December 31, 2022 |
December 31, 2021 |
|||||||
Salary and short – term benefits |
||||||||
Stock-based compensation |
||||||||
Termination benefits |
||||||||
29. |
Cash flow changes from financing activities |
Non-cash changes |
||||||||||||||||||||||||
January 1, 2022 |
Cash flows |
Conversion/ Other |
Foreign exchange |
Fair Value/ Amortization |
December 31, 2022 |
|||||||||||||||||||
Share capital |
( |
) |
— |
— |
||||||||||||||||||||
Lease liability |
( |
) |
— |
— |
— |
|||||||||||||||||||
Credit facility |
— |
— |
— |
|||||||||||||||||||||
Debentures |
( |
) |
— |
|||||||||||||||||||||
Total |
( |
) |
||||||||||||||||||||||
Non-cash changes |
||||||||||||||||||||||||
January 1, 2021 |
Cash flows |
Conversion/ Other |
Foreign exchange |
Fair Value/ Amortization |
December 31, 2021 |
|||||||||||||||||||
Share capital |
— |
— |
||||||||||||||||||||||
Lease liability |
( |
) |
— |
— |
||||||||||||||||||||
Credit facility |
— |
— |
— |
|||||||||||||||||||||
Debentures |
( |
) |
( |
) |
( |
) |
||||||||||||||||||
Convertible debentures |
— |
( |
) |
— |
— |
— |
||||||||||||||||||
Total |
( |
) |
||||||||||||||||||||||
Non-cash changes |
||||||||||||||||||||||||
January 1, 2020 |
Cash flows |
Conversion/ Other |
Foreign exchange |
Fair Value/ Amortization |
December 31, 2020 |
|||||||||||||||||||
Share capital |
— |
— |
||||||||||||||||||||||
Lease liability |
( |
) |
( |
) |
— |
— |
||||||||||||||||||
Credit facility |
( |
) |
— |
— |
||||||||||||||||||||
Debentures |
( |
) |
( |
) |
( |
) |
||||||||||||||||||
Convertible debentures |
— |
( |
) |
— |
||||||||||||||||||||
Total |
( |
) |
( |
) |
||||||||||||||||||||